AMGN Amgen Inc

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

$254.15  +2.85 (1.13%)
As of 05/07/2021 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  02/06/2001
Outstanding shares:  574,553,986
Average volume:  2,823,927
Market cap:   $144,385,416,682
Current dividend yield:  2.58%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    031162100
ISIN:        US0311621009
Sedol:      2023607
Valuation   (See tab for details)
PE ratio:   20.62
PB ratio:   15.67
PS ratio:   5.74
Return on equity:   75.91%
Net income %:   28.16%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy